<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>1,5-Anhydroglucitol</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/1,5-Anhydroglucitol">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.math.scripts.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.math.scripts.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.math.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.math.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">1<i>,</i>5-Anhydroglucitol</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>1,5-Anhydroglucitol</b>, also known as <b>1,5-AG</b>, is a naturally occurring monosaccharide found in nearly all foods. Blood concentrations of 1,5-anhydroglucitol decrease during times of hyperglycemia above 180<span>&nbsp;</span>mg/dL, and return to normal levels after approximately 2 weeks in the absence of hyperglycemia. As a result, it can be used for people with either type-1 or type-2 diabetes mellitus to identify glycemic variability or a history of high blood glucose even if current glycemic measurements such as hemoglobin A1c (HbA1c) and blood glucose monitoring have near normal values. Despite this possible use and its approval by the FDA, 1,5-AG tests are rarely ordered. There is some data suggesting that 1,5-AG values are useful to fill the gap and offer complementary information to HbA1c and fructosamine tests.<span class="mw-ref" id="cite_ref-1"><a href="#cite_note-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>

<span>
</span><table class="infobox bordered" style="border-collapse:collapse; width:22em; text-align:left; ;">
<caption style="text-align:center;">1,5-Anhydroglucitol</caption>
<tbody><tr> 
<td colspan="2" style="text-align:center; padding:2px;"><figure-inline><img src="../I/m/1%2C5-Anhydroglucitol.png" data-file-width="1072" data-file-height="649" data-file-type="bitmap" height="91" width="150"></figure-inline></td></tr>
<tr>
<th colspan="2" style="background: #f8eaba; text-align: center;">Names</th></tr>

<tr>

<td colspan="2" style="text-align:left;">IUPAC name
<div style="max-width:22em; word-wrap:break-word; padding-left:1.7em;">(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-2-(Hydroxymethyl)oxane-3,4,5-triol</div></td></tr>

<tr>


<td colspan="2" style="text-align:left;">Other names
<div style="max-width:22em; word-wrap:break-word; padding-left:1.7em;"><div class="plainlist"><ul><li>1,5-Anhydro-<small>D</small>-glucitol</li><li>1-Deoxy-<small>D</small>-glucopyranose</li><li>1,5-AG</li></ul></div></div></td></tr>

<tr>
<th colspan="2" style="background: #f8eaba; text-align: center;">Identifiers</th></tr>

<tr>

<td><div style="padding:0.1em 0;line-height:1.2em;">CAS Number</div></td>
<td><div class="plainlist"><ul><li><span><a href="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=154-58-5" class="external text external">154-58-5</a></span></li></ul></div></td></tr>

<tr>
<td><div style="padding:0.1em 0;line-height:1.2em;">3D model (JSmol)</div></td>
<td><div class="plainlist"><ul><li><span><a href="https://chemapps.stolaf.edu/jmol/jmol.php?model=C1%5BC%40%40H%5D%28%5BC%40H%5D%28%5BC%40%40H%5D%28%5BC%40H%5D%28O1%29CO%29O%29O%29O" class="external text external">Interactive image</a></span></li></ul></div></td></tr>

<tr>





<td>ChemSpider</td>
<td><div class="plainlist"><ul><li><span><a href="http://www.chemspider.com/Chemical-Structure.58485.html" class="external text external">58485</a></span></li></ul></div></td></tr>

<tr>

<td><span>ECHA InfoCard</span></td>
<td><a href="https://echa.europa.eu/substance-information/-/substanceinfo/100.005.301" class="external text external">100.005.301</a></td></tr>
<tr>
<td><span>EC Number</span></td>
<td><div class="plainlist"><ul><li>205-829-3</li></ul></div></td></tr>

<tr>





<td><div style="padding:0.1em 0;line-height:1.2em;">PubChem <abbr>CID</abbr></div></td>
<td><div class="plainlist"><ul><li><span><a href="https://pubchem.ncbi.nlm.nih.gov/compound/64960" class="external text external">64960</a></span></li></ul></div></td></tr>

<tr>

<td>UNII</td>
<td><div class="plainlist"><ul><li><span><a href="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=54BB3B7XMZ" class="external text external">54BB3B7XMZ</a></span></li></ul></div></td></tr>

<tr>

<td><div style="padding:0.1em 0;line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></div></td>
<td><div class="plainlist"><ul><li><span><a href="https://comptox.epa.gov/dashboard/DTXSID10893389" class="external text external">DTXSID10893389</a></span></li></ul></div></td></tr>

<tr>
<td colspan="2"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left; text-align:left; font-weight:normal; background:transparent;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="border-top:1px solid #ccc; padding:0.2em 0 0.2em 1.5em; text-align:left;"><div style="word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;">InChI=1S/C6H12O5/c7-1-4-6(10)5(9)3(8)2-11-4/h3-10H,1-2H2/t3-,4+,5+,6+/m0/s1</div><div style="word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;">Key:<span>&nbsp;</span>MPCAJMNYNOGXPB-SLPGGIOYSA-N</div></div></li></ul>
</div></td></tr>
<tr>
<td colspan="2"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left; text-align:left; font-weight:normal; background:transparent;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="border-top:1px solid #ccc; padding:0.2em 0 0.2em 1.6em; word-wrap:break-word; text-indent:-1.5em; text-align:left; font-size:11px; line-height:120%;">C1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O</div></li></ul>
</div></td></tr>

<tr>
<th colspan="2" style="background: #f8eaba; text-align: center;">Properties</th></tr>

<tr>
<td><div style="padding:0.1em 0;line-height:1.2em;">Chemical formula</div></td>

<td><span>C</span><sub>6</sub><span>H</span><sub>12</sub><span>O</span><sub>5</sub></td></tr>

<tr>
<td>Molar mass</td>

<td><span class="nowrap">164.157</span><span>&nbsp;</span>g·mol<sup>−1</sup> <span> </span></td></tr>

<tr>








<td colspan="2" style="text-align:left; background:#f8eaba;"><div style="margin:0 auto; text-align:left;"><div style="padding:0.1em 0;line-height:1.2em;">Except where otherwise noted, data are given for materials in their standard state (at 25<span>&nbsp;</span>°C [77<span>&nbsp;</span>°F], 100<span>&nbsp;</span>kPa).</div></div></td></tr>

<tr style="background:#f8eaba; border-top:2px solid transparent;"></tr>


<tr style="background:#f8eaba; border-top:2px solid transparent;">
<td colspan="2" style="text-align:center;">Infobox<span>&nbsp;</span>references</td></tr>

<tr style="background:#f8eaba;">
<td style="width:40%; max-height:1px; border-top:2px solid transparent; border-right:1px solid transparent;"></td>
<td style="width:60%; max-height:1px; border-top:2px solid transparent; border-left:1px solid transparent;"></td></tr>


</tbody></table>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>The role of 1,5-AG was first inferred by Akanuma in 1981 <span class="mw-ref" id="cite_ref-2"><a href="#cite_note-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> when he demonstrated decreased 1,5-AG levels in diabetic patients.  This observation was enhanced in 1983 when it was seen that plasma 1,5-AG fell to undetectable levels in diabetic patients who did not receive insulin.<span class="mw-ref" id="cite_ref-pmid6345028_3-0"><a href="#cite_note-pmid6345028-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span>  Further studies<span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> showed that patients receiving medication to lower blood glucose had lasting improvement in 1,5-AG levels.  If medication stopped, 1,5-AG decreased to pre-treatment levels.  In 2003, 1,5-AG began to be looked at by researchers in the United States and was shown to be a valuable short-term glycemic monitor.<span class="mw-ref" id="cite_ref-pmid12828817_5-0"><a href="#cite_note-pmid12828817-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-pmid152277408_6-0"><a href="#cite_note-pmid152277408-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span>  In 2006, 1,5-AG showed its most compelling clinical use when it was demonstrated that an assay (GlycoMark, developed by Nippon Kayaku, Inc.) for postprandial hyperglycemia was able to differentiate two patients who had similar, near goal, hemoglobin A1c values, yet very different glucose profiles as shown by continuous blood glucose monitoring - one of the patients having excessive glycemic variability.<span class="mw-ref" id="cite_ref-pmid16731998_7-0"><a href="#cite_note-pmid16731998-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> In 2014, 1,5-AG in saliva was shown to mirror 1,5-AG in blood, indicating that it could be used as a noninvasive marker of short-term glycemic control.<span class="mw-ref" id="cite_ref-pmid24423354_8-0"><a href="#cite_note-pmid24423354-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Underlying_physiology">Underlying physiology</h2></summary>
    

<p>1,5-AG is ingested from nearly all foods during the course of a regular diet and is nearly 100% non-metabolized. It is carried in the blood stream and filtered by the glomerulus, where it enters the kidney. Once in the kidney, 1,5-AG is re-absorbed back into the blood through the renal proximal tubule.  A small amount, equal to the amount ingested, of 1,5-AG is released in the urine to maintain a constant amount in the blood and tissue.</p>

<p>Glucose is a competitive inhibitor of the re-absorption. If blood glucose values rise over 180<span>&nbsp;</span>mg/dL for any period of time, the kidney cannot re-absorb all glucose back into the blood, leading to increased excretion in the urine (glucosuria). As a result, blood levels of 1,5-AG decrease immediately, and continue to decrease until glucose values go below 180<span>&nbsp;</span>mg/dL.  Once the hyperglycemia is corrected, 1,5-AG begins to be re-absorbed from the kidney back into the blood at a steady rate.  If a person's glucose levels remain below 180<span>&nbsp;</span>mg/dL for approximately 4 weeks, 1,5-AG will return to its normal levels. As a result, measurement of the level of 1,5-AG in the blood is a test for a recent history of hyperglycemic episodes.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="GlycoMark_diagnostic_assay">GlycoMark diagnostic assay</h2></summary>
    

<p>The GlycoMark test is cleared by the FDA to be sold and marketed for the intermediate term monitoring of glycemic control in people with diabetes. It is available through most major reference laboratories, including Quest Diagnostics and Labcorp or may be performed in a hospital or physician's office. A comprehensive evaluation of the assay has been described in the literature.<span class="mw-ref" id="cite_ref-pmid15530479_9-0"><a href="#cite_note-pmid15530479-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>

<p>The assay can be run on almost any open chemistry analyzer, including those found in physician office laboratories. Two reactions take place during the measurement:</p>

<p>Reaction 1 is a pretreatment of the sample performed by adding glucokinase to convert glucose to <a href="Glucose_6-phosphate.htm" title="Glucose 6-phosphate">glucose 6-phosphate</a> in the presence of <a href="Adenosine_triphosphate.htm" title="Adenosine triphosphate">adenosine triphosphate</a>, pyruvate kinase, and phosphoenol pyruvate.  The purpose of this step is to alter glucose, which is found in the blood sample, so that it can not react during reaction 2.</p>

<p>Reaction 2 uses pyranose oxidase to oxidize the second hydroxyl of 1,5-AG, generating <a href="Hydrogen_peroxide.htm" title="Hydrogen peroxide">hydrogen peroxide</a>.  The amount of hydrogen peroxide is detected by colorimetry using peroxidase, and is in direct relationship to the serum 1,5-AG concentration.</p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Interpretation_of_results">Interpretation of results</h3></summary>
    

<p>Results are in μg/mL. Lower values indicate worsening glucose control, with more frequent and prolonged glucose values over 180<span>&nbsp;</span>mg/dL. 10<span>&nbsp;</span>μg/mL of 1,5-AG correlates to an average post meal glucose of 185<span>&nbsp;</span>mg/dL, and is the target value in people with diabetes.  Values over 10<span>&nbsp;</span>μg/mL indicate glucose on average is below 180<span>&nbsp;</span>mg/dL. Those with values below 10<span>&nbsp;</span>μg/mL could benefit from nutritional counseling, and medications which target post meal glucose spikes, such as <a href="Pramlintide.htm" title="Pramlintide">pramlintide</a>, <a href="Exenatide.htm" title="Exenatide">exenatide</a>, <a href="Sitagliptin" title="Sitagliptin">sitagliptin</a>, saxagliptin, <a href="Repaglinide.htm" title="Repaglinide">repaglinide</a> or rapid acting insulins.</p>

<table class="wikitable" style="text-align:center" align="center">
<tbody><tr>
<th>GlycoMark<br>(μg/mL)</th><th>Approximate Mean Postmeal<br>Maximum Glucose (mg/dL)</th></tr>
<tr>
<td>&gt;<span>&nbsp;</span>12</td><td>&lt;<span>&nbsp;</span>180</td></tr>
<tr>
<td>10</td><td>185</td></tr>
<tr>
<td>8</td><td>190</td></tr>
<tr>
<td>6</td><td>200</td></tr>
<tr>
<td>4</td><td>225</td></tr>
<tr>
<td>&lt;<span>&nbsp;</span>2</td><td>&gt;<span>&nbsp;</span>290</td></tr>
</tbody></table>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Glycated hemoglobin</li>
<li>Diabetes</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-1"> <span id="mw-reference-text-cite_note-1" class="mw-reference-text"><cite id="CITEREFDungan2008" class="citation journal cs1">Dungan, Kathleen M. (Jan 2008). "1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions". <i>Expert Rev Mol Diagn</i>. <b>8</b> (1): 9–19. doi:<a href="https://doi.org/10.1586%2F14737159.8.1.9" class="external text external">10.1586/14737159.8.1.9</a>. PMID<span>&nbsp;</span><a href="https://pubmed.ncbi.nlm.nih.gov/18088226" class="external text external">18088226</a>.</cite></span></li><li id="cite_note-2"> <span id="mw-reference-text-cite_note-2" class="mw-reference-text"><cite id="CITEREFAkanumaOgawaYamanouchiMashiko1981" class="citation journal cs1">Akanuma Y, Ogawa K, Yamanouchi T, Mashiko S, Oka Y, Kosaka K, Akanuma H (1981). "Decreased plasma 1,5-anhydroglucitol in diabetic patients". <i>Diabetes</i>. <b>30</b> (Suppl. 1): 124A.</cite></span></li><li id="cite_note-pmid6345028-3"> <span id="mw-reference-text-cite_note-pmid6345028-3" class="mw-reference-text"><cite id="CITEREFYoshiokaSaitohNegishiFujisawa1983" class="citation journal cs1">Yoshioka S, Saitoh S, Negishi C, Fujisawa T, Takatani O, Imura M, Funagashi M (1983). "Variations of 1-deoxyglucose (1,5-anhydroglucitol) content in plasma from patients with insulin-dependent diabetes mellitus". <i>Clin. Chem</i>. <b>29</b> (7): 1396–8. PMID<span>&nbsp;</span><a href="https://pubmed.ncbi.nlm.nih.gov/6345028" class="external text external">6345028</a>.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><cite id="CITEREFYamanouchi1996" class="citation journal cs1">Yamanouchi T,  et al. (1996). "Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycemic control". <i>The Lancet</i>. <b>347</b> (9014): 1514–8. doi:<a href="https://doi.org/10.1016%2FS0140-6736%2896%2990672-8" class="external text external">10.1016/S0140-6736(96)90672-8</a>. PMID<span>&nbsp;</span><a href="https://pubmed.ncbi.nlm.nih.gov/8684103" class="external text external">8684103</a>.</cite></span></li><li id="cite_note-pmid12828817-5"> <span id="mw-reference-text-cite_note-pmid12828817-5" class="mw-reference-text"><cite id="CITEREFBuseFreemanEdelmanJovanovic2003" class="citation journal cs1">Buse JB, Freeman JL, Edelman SV, Jovanovic L, McGill JB (2003). "Serum 1,5-anhydroglucitol(GlycoMark<sup>TM</sup>): a short-term glycemic marker". <i>Diabetes Technol Ther</i>. <b>5</b> (3): 355–63. doi:<a href="https://doi.org/10.1089%2F152091503765691839" class="external text external">10.1089/152091503765691839</a>. PMID<span>&nbsp;</span><a href="https://pubmed.ncbi.nlm.nih.gov/12828817" class="external text external">12828817</a>.</cite></span></li><li id="cite_note-pmid152277408-6"> <span id="mw-reference-text-cite_note-pmid152277408-6" class="mw-reference-text"><cite id="CITEREFMcGillColeNowatzkeHoughton2004" class="citation journal cs1">McGill JB, Cole TG, Nowatzke W, Houghton S, Ammirati EB, Gautille T, Sarno MJ (2004). <a href="https://doi.org/10.2337/diacare.27.8.1859" class="external text external">"Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark<sup>TM</sup> assay"</a>. <i>Diabetes Care</i>. <b>27</b> (8): 1859–65. doi:<span class="cs1-lock-free"><a href="https://doi.org/10.2337%2Fdiacare.27.8.1859" class="external text external">10.2337/diacare.27.8.1859</a></span>. PMID<span>&nbsp;</span><a href="https://pubmed.ncbi.nlm.nih.gov/15277408" class="external text external">15277408</a>.</cite></span></li><li id="cite_note-pmid16731998-7"> <span id="mw-reference-text-cite_note-pmid16731998-7" class="mw-reference-text"><cite id="CITEREFDunganBuseLargayKelly2006" class="citation journal cs1">Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Wittlin S (2006). <a href="https://doi.org/10.2337/dc06-1910" class="external text external">"1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes"</a>. <i>Diabetes Care</i>. <b>29</b> (6): 1214–9. doi:<span class="cs1-lock-free"><a href="https://doi.org/10.2337%2Fdc06-1910" class="external text external">10.2337/dc06-1910</a></span>. PMID<span>&nbsp;</span><a href="https://pubmed.ncbi.nlm.nih.gov/16731998" class="external text external">16731998</a>.</cite></span></li><li id="cite_note-pmid24423354-8"> <span id="mw-reference-text-cite_note-pmid24423354-8" class="mw-reference-text"><cite id="CITEREFMook-KanamoriSelimTakiddinAl-Homsi2013" class="citation journal cs1">Mook-Kanamori DO, Selim MM, Takiddin AH, Al-Homsi H, Al-Mahmoud KA, Al-Obaidli A, Zirie MA, Rowe J, Yousri NA, Karoly ED, Kocher T, Sekkal Gherbi W, Chidiac OM, Mook-Kanamori MJ, Abdul Kader S, Al Muftah WA, McKeon C, Suhre K (2013). <a href="https://doi.org/10.1210/jc.2013-3596" class="external text external">"1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control"</a>. <i>J Clin Endocrinol Metab</i>. <b>99</b> (3): 479–83. doi:<span class="cs1-lock-free"><a href="https://doi.org/10.1210%2Fjc.2013-3596" class="external text external">10.1210/jc.2013-3596</a></span>. PMID<span>&nbsp;</span><a href="https://pubmed.ncbi.nlm.nih.gov/24423354" class="external text external">24423354</a>.</cite></span></li><li id="cite_note-pmid15530479-9"> <span id="mw-reference-text-cite_note-pmid15530479-9" class="mw-reference-text"><cite id="CITEREFNowatzkeSarnoBirchStickle2004" class="citation journal cs1">Nowatzke W, Sarno MJ, Birch NC, Stickle DF, Eden T, Cole TG (2004). "Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark<sup>TM</sup>) and determination of reference intervals on the Hitachi 917 analyzer". <i>Clin Chim Acta</i>. <b>350</b> (1–2): 201–9. doi:<a href="https://doi.org/10.1016%2Fj.cccn.2004.08.013" class="external text external">10.1016/j.cccn.2004.08.013</a>. PMID<span>&nbsp;</span><a href="https://pubmed.ncbi.nlm.nih.gov/15530479" class="external text external">15530479</a>.</cite></span></li></ol></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><figure-inline class="noviewer"><img src="../I/m/Commons-logo.svg.png" data-file-width="1024" data-file-height="1376" data-file-type="drawing" height="16" width="12"></figure-inline><span> Media related to </span><a href="https://commons.wikimedia.org/wiki/Category:1,5-Anhydroglucitol" title="commons:Category:1,5-Anhydroglucitol" class="external"><span style=" ">1,5-Anhydroglucitol</span></a><span> at Wikimedia Commons</span></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Diabetes_(E10–E14,_250)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Diabetes_(E10–E14,_250)" style="font-size:114%;margin:0 4em">Diabetes (<span class="new">E10–E14</span>, 250)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Types</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Type 1</li>
<li>Type 2</li>
<li>LADA</li>
<li>Gestational diabetes
<ul><li>Diabetes and pregnancy</li></ul></li>
<li>Prediabetes
<ul><li>Impaired fasting glucose</li>
<li>Impaired glucose tolerance</li></ul></li>
<li>Insulin resistance</li>
<li>KPD</li>
<li>MODY</li>
<li>Neonatal
<ul><li>Transient</li>
<li>Permanent</li></ul></li>
<li>Type 3c (pancreatogenic)</li>
<li>Type 3</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Blood tests</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Blood sugar level</li>
<li>Glycosylated hemoglobin</li>
<li>Glucose tolerance test</li>
<li>Postprandial glucose test</li>
<li>Fructosamine</li>
<li>Glucose test</li>
<li>C-peptide</li>
<li>Noninvasive glucose monitor</li>
<li>Insulin tolerance test</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Management</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Diabetic diet</li>
<li>Anti-diabetic drugs</li>
<li>Insulin therapy
<ul><li>intensive</li>
<li>conventional</li>
<li>pulsatile</li></ul></li>
<li>Cure
<ul><li>Embryonic stem cells</li>
<li>Artificial pancreas</li></ul></li>
<li>Other
<ul><li>Gastric bypass surgery</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Complications</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Diabetic comas
<ul><li>Hypoglycemia</li>
<li>Ketoacidosis</li>
<li>Hyperosmolar hyperglycemic state</li></ul></li>
<li>Diabetic foot
<ul><li>ulcer</li>
<li>Neuropathic arthropathy</li></ul></li>
<li>Organs in diabetes
<ul><li>Blood vessels</li>
<li>Muscle</li>
<li>Kidney</li>
<li>Nerves</li>
<li>Retina</li>
<li>Heart</li></ul></li>
<li>Diabetic skin disease
<ul><li>Diabetic dermopathy</li>
<li>Diabetic bulla</li>
<li>Diabetic cheiroarthropathy</li>
<li>Neuropathic ulcer</li></ul></li>
<li>Hyperglycemia</li>
<li>Hypoglycemia</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Glossary of diabetes</li>
<li>History of diabetes</li>
<li>Notable people with type 1 diabetes</li></ul>
</div></td></tr></tbody></table></div>

<meta property="mw:PageProp/categorydefaultsort" content="Anhydroglucitol, 1, 5-">

<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png");background-image:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg");background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png");background-image:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg");background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png");background-image:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg");background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png");background-image:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg");background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-04-17" href="https://en.wikipedia.org/wiki/?title=1%2C5-Anhydroglucitol&amp;oldid=951479610">Wikipedia</a>. The text is licensed under <a class="external text" href="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>